Nursing-Led Deep Vein Thrombosis Prevention in Neurosurgery

NCT ID: NCT07330661

Last Updated: 2026-01-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1286 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-01

Study Completion Date

2024-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to see if a nurse-led program (early movement, leg-sleeve squeezes, and blood tests) can prevent dangerous leg blood clots in adults who have just had brain or spine surgery.

Main questions it aims to answer:

* Does the program lower the number of clots within 30 days after surgery?
* Is the program safer and more accurate than the usual clot-risk score nurses already use?

Researchers will compare patients who receive the nurse-led program with patients who receive standard hospital care.

Participants will:

* Be randomly assigned to one of the two groups.
* Have regular leg ultrasounds to check for clots.
* Wear a small activity tracker if they are in the nurse-led group.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Deep Vein Thrombosis (DVT)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Nurse-led prevention group

In addition to routine post-operative care, participants assigned to the nurse-led prevention arm receive:

* Graded early-movement plan starting within 24 h of surgery
* Unconscious patients: passive leg exercises 10-15 min, 3× daily
* Conscious patients: assisted leg, sitting and walking sessions escalated daily (target ≥ 40 min total activity, logged automatically by a wrist-band activity tracker)
* Intermittent pneumatic compression (IPC)
* 2 h/session, 2× daily, 30-45 mmHg while in bed, continued until independent walking
* D-dimer blood checks on post-op days 1, 3, 7 and 14; any rise ≥ 20 % or level \> 2 mg/L triggers an extra leg ultrasound
* Continuous safety watch (heart rate, blood pressure, intracranial pressure if monitored); IPC or movement is paused if pressure \> 20 mmHg or vital signs become unstable

All steps are recorded in the electronic nursing chart and coordinated by a neurosurgery-rehabilitation-data

Group Type EXPERIMENTAL

nurse-led program (early movement, leg-sleeve squeezes, and blood tests)

Intervention Type BEHAVIORAL

Graded early-movement plan starting within 24 h of surgery

* Unconscious patients: passive leg exercises 10-15 min, 3× daily
* Conscious patients: assisted leg, sitting and walking sessions escalated daily (target ≥ 40 min total activity, logged automatically by a wrist-band activity tracker) Intermittent pneumatic compression (IPC)
* 2 h/session, 2× daily, 30-45 mmHg while in bed, continued until independent walking D-dimer blood checks on post-op days 1, 3, 7 and 14; any rise ≥ 20 % or level \> 2 mg/L triggers an extra leg ultrasound Continuous safety watch (heart rate, blood pressure, intracranial pressure if monitored); IPC or movement is paused if pressure \> 20 mmHg or vital signs become unstable

Standard post-neurosurgical care group

Participants in the control arm receive the hospital's standard post-neurosurgical care, which follows current Chinese and U.S. VTE-guidelines and includes:

* Routine hydration and general health-education advice
* Graduated compression stockings (class II, knee-high) worn 8-12 h each day until the patient is walking independently
* Gentle passive leg movements (about 10 min, 1-2 times daily) when nursing staff judge it safe
* Low-molecular-weight heparin (40 mg enoxaparin subcutaneous once daily) only for patients judged to be at low bleeding risk (Caprini 4-7) and with no intracranial hemorrhage

No systematic Caprini re-assessments, no scheduled early-mobilization protocol, no IPC machines, no D-dimer surveillance, and no activity trackers are used.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

nurse-led program (early movement, leg-sleeve squeezes, and blood tests)

Graded early-movement plan starting within 24 h of surgery

* Unconscious patients: passive leg exercises 10-15 min, 3× daily
* Conscious patients: assisted leg, sitting and walking sessions escalated daily (target ≥ 40 min total activity, logged automatically by a wrist-band activity tracker) Intermittent pneumatic compression (IPC)
* 2 h/session, 2× daily, 30-45 mmHg while in bed, continued until independent walking D-dimer blood checks on post-op days 1, 3, 7 and 14; any rise ≥ 20 % or level \> 2 mg/L triggers an extra leg ultrasound Continuous safety watch (heart rate, blood pressure, intracranial pressure if monitored); IPC or movement is paused if pressure \> 20 mmHg or vital signs become unstable

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years
* Any elective or emergency craniotomy, spinal, or other neurosurgical procedure
* Expected post-operative hospital stay ≥ 3 days
* Patient or legally authorized representative willing and able to give written informed consent

Exclusion Criteria

* Pre-operative ultrasound or imaging proven DVT or pulmonary embolism
* Known hereditary bleeding disorder (e.g., hemophilia) or platelet count \< 50 × 10⁹/L
* Chronic therapeutic anticoagulation (warfarin, DOAC, heparin) that cannot be safely stopped, or need for full-dose post-op anticoagulation
* Severe liver disease (Child-Pugh class C) or eGFR \< 30 mL/min/1.73 m²
* Life-limiting co-morbidity with expected survival \< 30 days
* Pregnancy or breastfeeding
* Current participation in another interventional VTE trial
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

West China Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zhigang Lan

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

West China Hospital of Sichuan University

Chengdu, Sichuan, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

WestChinaH-HX-2025-010

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Thrombohemorrhagic Complications of COVID-19
NCT06223945 ACTIVE_NOT_RECRUITING NA